saikosaponin d has been researched along with Colitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, Y; Li, J; Li, M; Li, P; Ren, J; Wu, M; Xie, Y; Xiong, W; Xue, H; Yan, D; Zhong, G | 1 |
| Meng, LJ; Wang, N; Xia, YC; Yang, L; Zhang, LC; Zhou, F | 1 |
2 other study(ies) available for saikosaponin d and Colitis
| Article | Year |
|---|---|
Saikosaponin-d ameliorates dextran sulfate sodium-induced colitis by suppressing NF-κB activation and modulating the gut microbiota in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colitis, Ulcerative; Cytokines; Dextran Sulfate; Disease Models, Animal; Feces; Gastrointestinal Microbiome; Humans; Inflammation Mediators; Male; Mice; Mice, Inbred BALB C; Mucins; NF-kappa B; Oleanolic Acid; Saponins; Signal Transduction | 2020 |
Saikosaponin A protects against dextran sulfate sodium-induced colitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Colitis; Colon; Dextran Sulfate; Interleukin-1beta; Liver X Receptors; Male; Mice, Inbred C57BL; NF-kappa B; Oleanolic Acid; Saponins; Tumor Necrosis Factor-alpha | 2019 |